Mérieux Développement and Paladin Capital Group Co-lead $55.5 Million Series C Financing Into Inscripta, a Leading Company in the Field of Gene Editing, in Preparation for Platform Expansion and Commercial Launch

SAN FRANCISCO, LYON, France and BOSTON, February 28, 2018 /PRNewswire/ -- Investment will accelerate development and commercialization of gene-editing tools including enzymes, reagents, instrumentation, and software. Mérieux Développement and Paladin Capital Group announced the...

from PR Newswire: //http://ift.tt/2Fdn0YU